SCHEMBL1015206

SCHEMBL1015206

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(Cc2ccco2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
ALDH1A1 P00352 6/20 0.47
POLB P06746 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPK10 P53779 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SERPINE1 P05121 1/20 0.45
RXFP1 Q9HBX9 2/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 7/20 0.44
HPGD P15428 6/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HSD17B10 Q99714 5/20 0.43
TSHR P16473 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013840 0.91 SERPINE1 (0.55) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1013870 0.87 ALDH1A1 (0.45) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1014869 0.86 SERPINE1 (0.53) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1016295 0.84 LCLAT1 (0.49) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1015672 0.80 ALDH1A1 (0.58) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL1018800 0.80 GRIK1 (0.47) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1015662 0.79 SERPINE1 (0.64) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1797516 0.78 ALDH1A1 (0.50) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL1016790 0.78 SERPINE1 (0.47) KDM4EALDH1A1MEN1KMT2ASERPINE1
SCHEMBL1016303 0.78 SERPINE1 (0.55) KDM4EALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 KDM4E 4108/4885ALDH1A1 888/4885POLB 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.